Ultragenyx: Overcoming T echnological Challenges to Fast-Track R&D CASE STUDY Company Overview: A Rare Disease Pioneer The Challenge: Decreasing Analysis Time of Multi-Omics Data Advancing Rare Disease Therapeutics with Ultragenyx, a biopharmaceutical company based in Novato, CA, is committed to bringing novel products to patients for the treatment of rare and ultra-rare diseases, with a focus on serious and debilitating genetic diseases. The company has rapidly built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need, yet clear underlying biology. Ultragenyx’s strategy is predicated upon time and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with

Join for free to read